Business Results for 2Q (August 8, 2019)Business Results for 1Q (May 14, 2019)Business Results (February 13, 2019)Business Results for 3Q (November 14, 2018)Business Results for 2Q (August 8, 2018)Business Results for 1Q (May 11, 2018)Business Results (February 14, 2018)Business Results for 3Q (November 14, 2017)Business Results for 2Q (August 8, 2017)Business Results for 1Q (May 12, 2017)Business Results (February 14, 2017)Business Results for 3Q (November 11, 2016)Business Results for 2Q (August 9, 2016)Business Results for 1Q (May 13, 2016)Business Results (February 12, 2016)Business Results for 3Q (November 13, 2015)Business Results for 2Q (August 7, 2015)Business Results for 1Q (May 13, 2015)Business Results (February 13, 2015)Business Results for 2Q (November 13, 2014)Business Results for 1Q (August 8, 2014)Business Results (May 14, 2014)Business Results for 3Q (February 13, 2014)Business Results for 2Q (November 13, 2013)Business Results for 1Q (August 8, 2013)Business Results (May 14, 2013)Business Results for 3Q (February 13, 2013)Business Results for 2Q (November 13, 2012)Business Results for 1Q (August 9, 2012)Business Results (May 11, 2012)Business Results for 3Q (February 10,2012)Business Results for 2Q (November 10,2011)Business Results for 1Q (August 9,2011)Business Results (May 12,2011)Business Results for 3Q (February 14,2011)Business Results for 2Q (December 15,2010)Business Results (May 14,2010)Business Results (May 15,2009)
Attachments
Original document
Permalink
Disclaimer
Otsuka Holdings Co. Ltd. published this content on 08 August 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 August 2019 04:49:08 UTC
Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity:
- manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices;
- manufacture and sale of nutraceutical products (25.1%): functional foods and beverages, OTC products, nutritional supplements;
- production of mineral waters, beverages and foods (2.1%);
- other (7.5%): manufacture of functional chemicals and fine chemicals, provision of logistics services, manufacture of electronic products, etc.
Net sales by source of income are divided between sales of products (93.8%), sales of licences and royalties (1.8%) and other (4.4%).
Net sales are distributed geographically as follows: Japan (43.2%), North America (34%),